Low Grade Ovarian Cancer: The Expert Consensus,’ with Drs. Rachel Grisham, David Gershenson, and Brian Slomovitz

In this rebroadcasted episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Drs. Rachel Grisham, David Gershenson, and Brian Slomovitz to discuss "Low Grade Ovarian Cancer: The Expert Consensus". 

 

Highlights:  

• A panel of experts convened in October 2022 to discuss recent scientific and clinical progress, resulting in a consensus document that provides recommendations for diagnosis, treatment, and ongoing research to improve patient care of low-grade serous ovarian cancer. 
• Alterations affecting the MAPK pathway are frequent in low-grade serous ovarian cancer and provide prognostic information 
• Recent advances in the use of targeted therapy (in particular with novel MEK inhibitor and endocrine therapy regimens) have led to unprecedented response rates in patients with recurrent low-grade serous ovarian cancer